Optimus Pharma gets DCGI nod for Phase III trials of Molnupiravir for COVID-19 treatment
As per the clinical trial protocol approved, 2500 subjects with mild to moderate COVID-19 will be randomised in the study in a 1:1…
Author
Goldman Sachs invests in Aragen Life Sciences
These shares were previously held by ChrysCapital and other existing shareholders
BDR Pharma signs voluntary licensing agreement with Lilly for baricitinib
Lilly had recently announced seven other voluntary license agreements with major drug manufacturers in India for the production of…
Anupam Rasayan receives Rs 540 crore order from two MNCs dealing in life sciences chemicals
The tenure of the contract is for five years
Adar Poonawalla sells stake in Panacea Biotec
He had a 5.15 per cent shareholding in the company and the total value of the transaction was a little over Rs 118 crores
Boehringer Ingelheim allocates one million Euros to fight COVID-19 in India
The package to focus on medical, sustenance support
IIT Madras, MIT researchers develop human brain tissues from 3D printed bioreactor
Objective is to observe brain tissues while they grow and develop a technology that can potentially accelerate medical and…
CKD-hyperparathyroidism, hyperphosphatemia, hyperkalemia market to grow at 6.9% CAGR by 2030:…
Historically, the CKD-HPT, HP, and HK disease space mainly consisted of reformulations of existing drugs and repurposed drugs from…
Shilpa Medicare partners with Dr Reddy’s for Sputnik V vaccine production
The companies are also exploring the option to manufacture Sputnik Light, a single-dose version of the vaccine in the near future